Edwards Lifesciences | EW - Trade Creditors


Edwards Lifesciences reported $199.7M in Trade Creditors for its fiscal quarter ending in September of 2026.





Trade Creditors Change Date
Abbott USD 4.68B 439M Mar/2026
Artivion USD 17.63M 3.24M Sep/2026
AtriCure USD 80.24M 1.5M Sep/2026
Baxter International USD 1.02B 10M Sep/2026
Becton, Dickinson and Co. USD 6.11B 173M Jun/2026
Boston Scientific USD 1.25B 19M Sep/2026
Cooper Companies USD 251.2M 17.9M Jun/2026
Dexcom USD 2.08B 134.8M Jun/2026
Edwards Lifesciences USD 199.7M 10.8M Sep/2026
Globus Medical USD 107.43M 487K Sep/2026
ICU Medical USD 142.99M 6.18M Sep/2026
Inogen USD 21.22M 684K Sep/2025
Insulet USD 162.2M 38.9M Sep/2026
Integra LifeSciences USD 82.64M 5.31M Jun/2026
Intuitive Surgical USD 2.56B 645M Sep/2026
J&J USD 9.32B 94M Sep/2026
Medtronic USD 2.7B 51M Jun/2026
Merit Medical Systems USD 70.74M 2.88M Jun/2026
Stryker USD 1.66B 71M Jun/2026
Tandem Diabetes Care USD 74.8M 10.67M Sep/2026
Teleflex USD 142.87M 423K Sep/2026
Zimmer Biomet Holdings USD 357.5M 5.1M Sep/2026